Trial IRCT20200318046812N1
Publication Solaymani-Dodaran M, Int Immunopharmacol, 2021
Primary outcome on the report: Number of admissions to the intensive care unit

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.